George and Esther Gross Presidential Professor of
Pediatrics and Medicine
Chief of the Division of Pediatric Infectious Diseases
University of Utah
Salt Lake City, UT
- Antiviral therapy in HIV
- HIV epidemiology
- HIV and women
- Pediatric HIV
- Adolescent HIV
Dr Pavia is Professor of Pediatrics and Medicine and Chief of the Division of Pediatric Infectious Diseases at the University of Utah Health Sciences Center and Primary Children's Hospital. He is involved in the care of adults, pregnant women, and children with HIV. His research interests include HIV therapy, enteric infections, and emerging infections.
- National and Global Public Health Committee, Infectious Disease Society of America
- Emerging Infectious Committee, Infectious Disease Society of America
- Nominations Committee, Pediatric Infectious Disease Society
- HIV and TB policy committee, Society for Health Care Epidemiology
- Society for Pediatric Research
- HIV Medicine Association
- American College of Physicians
- American Academy of Pediatrics
- George and Esther Gross Presidential Professor
- Department of Pediatrics Teaching Award, 2001-2002
- Citation, Public Health Service
- Society for Pediatric Research
- Sigma Xi
- Brown University, AB (1978)
- Brown University, MD (1981)
- Dartmouth Hitchcock Medical Center, Internal Medicine Resident, Chief Resident (1981-1985)
- Centers for Disease Control, Epidemic Intelligence Service and Preventive Medicine Resident (1986-1989)
- University of Utah, Infectious Disease Fellow (1989-1990)
- Spruance SL, Pavia AT, Mellors JW, Murphy RW, Gathe J, Stool E, Jemsek J, Dellamonica P, Cross A, Dunkle L, for the BMS Stavudine/019 Study Group. Clinical efficacy of monotherapy with stavudine compared to zidovudine in HIV-infected zidovudine-experienced patients: a randomized controlled trial. Ann Intern Med. 1997;126:355-363.
- Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew LW, Toole J, Jaffe HS, Hellmann N, Kahn J. The safety and efficacy of adefovir dipivoxil, a novel anti-HIV therapy, in HIV infected adults. J Infect Dis. 1997;176:1517-1523.
- Meadows KP, Tyring SK, Pavia AT, Rallis TM. Resolution of recalcitrant molluscum contagiosum lesions in HIV-infected patients treated with cidofovir. Arch Dermatol. 1997;133:987-990.
- Davey R, Murphy R, Graziano F, Boswell S, Pavia A, Cancio M, Nadler J, Chaitt D, Dewar R, Sahner D, Duliege A-M, Capra W, Leong WP, Giedlin M, Lane C, Kahn J. Immunologic and virologic effects of subcutaneous IL-2 in combination with antiretroviral therapy: a randomized clinical trial. JAMA. 2000;284:183-189.
- Pavia AT. Stavudine. In: Dolin RD, Masur H, Saag M, eds. AIDS Therapy. 2nd ed. New York, NY: Churchill-Livingstone; 2001.
- Pavia AT, Christenson JC. Pediatric AIDS. In: Sande MA, Volberding PA, eds. The Medical Management of AIDS. 6th ed. New York, NY: WB Saunders: 1999.
- Bonkowsky J, Christenson JC, Nixon GW, Pavia AT. Cerebral aneurysms in a child with AIDS during a period of rapid immune reconstitution. J Child Neurology Pediatrics. In press.
- Adderson EA, Spencer L, Kimball A, Hindiye M, Carroll K, Mottice S, Korgenski EK, Byington CL, Christenson JC, Pavia AT. Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling H influenzae type b: emerging pathogen in the vaccine era? In press.
- Pavia AT, Gulick R, Eron EJ, Squires K, Murphy R, Shoelkopf N, Hellmann N, Huang W, Parkin N, Grosso RA, Stevens MR, for the START I and II protocol teams. Genotypic resistance at baseline fails to predit outcome among chronically infected, antiretroviral therapy-naive patients in two large trials of protease inhibitor-based regimens. In press.
- Pavia AT. Infants and children. In: Cohen PT, Sande MA, Volberding PA, eds. The AIDS Knowledge Base. 4th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins.